← SynDRA
APINOCALTAMIDE
SynDRA canonical compound SYN0039336 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CACNA1G |
|---|
| Mechanism of action | calcium channel blocker |
|---|
| Indication | epilepsy |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
Mechanisms of action (all sources)
- CACNA1H BLOCKER
- Voltage-gated T-type calcium channel blocker
- CACNA1G BLOCKER
- CACNA1I BLOCKER
- CACNA1G INHIBITOR
- CACNA1H INHIBITOR
- CACNA1I INHIBITOR
- calcium channel blocker
Drug classes
Cross-references
Synonyms
- Apinocaltamida
- ACT-709478
- NBI-827104
- ACT 709478
- 3Z7U1U8Z9E
- RefChem:109452
- apinocaltamida
- C22H18F3N5O
- ACT709478
- apinocaltamidum
- MFCD31813695
- Apinocaltamide [INN]
- A1AHK
- Apinocaltamide [WHO-DD]
- Apinocaltamide (USAN/INN)
- UNII-3Z7U1U8Z9E
- APINOCALTAMIDE [USAN]
- orb1707717
- SCHEMBL17316866
- SCHEMBL29903343
- GTPL12647
- CHEBI:194340
- LSYANGLAZUZYFX-UHFFFAOYSA-N
- EX-A3130
- NYC65158
- BDBM50452245
- NBI827104
- AKOS037648975
- compound 66b [PMID: 29116786]
- BS-16157
- DA-60786
- SY412504
- HY-112723
- CS-0062884
- D12910
- D80992
- T14120
- F840847
Look up APINOCALTAMIDE in the interactive SynDRA portal →